Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Shaw

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|October 30, 2003
Development of chiral nucleophilic pyridine catalysts: applications in asymmetric quaternary carbon synthesisScott A Shaw, Pedro Aleman, Edwin Vedejs
Journal of the American Chemical Society|December 20, 2008
AcOLeDMAP and BnOLeDMAP: conformationally restricted nucleophilic catalysts for enantioselective rearrangement of indolyl acetates and carbonatesTrisha A Duffey, Scott A Shaw, Edwin Vedejs
Tetrahedron|October 25, 2011
Sporolide B: Synthetic StudiesJeffery A Gladding, James P Bacci, Scott A Shaw, et al.
Journal of the American Chemical Society|January 19, 2006
Enantioselective TADMAP-catalyzed carboxyl migration reactions for the synthesis of stereogenic quaternary carbonScott A Shaw, Pedro Aleman, Justin Christy, et al.
Angewandte Chemie (International Ed. in English)|July 7, 2016
Nickel-Catalyzed Cross-Coupling of Redox-Active Esters with Boronic AcidsJie Wang, Tian Qin, Tie-Gen Chen, et al.
Angewandte Chemie (International Ed. in English)|June 22, 2017
Decarboxylative AlkynylationJoel M Smith, Tian Qin, Rohan R Merchant, et al.
Nature|April 21, 2017
Decarboxylative alkenylationJacob T Edwards, Rohan R Merchant, Kyle S McClymont, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Triazolopyridine Myeloperoxidase InhibitorsNicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Medchemcomm|August 16, 2018
Triazolopyrimidines identified as reversible myeloperoxidase inhibitorsFranck Duclos, Lynn M Abell, David G Harden, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidaseScott A Shaw, Benjamin P Vokits, Andrew K Dilger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|October 30, 2003
Development of chiral nucleophilic pyridine catalysts: applications in asymmetric quaternary carbon synthesisScott A Shaw, Pedro Aleman, Edwin Vedejs
Journal of the American Chemical Society|December 20, 2008
AcOLeDMAP and BnOLeDMAP: conformationally restricted nucleophilic catalysts for enantioselective rearrangement of indolyl acetates and carbonatesTrisha A Duffey, Scott A Shaw, Edwin Vedejs
Tetrahedron|October 25, 2011
Sporolide B: Synthetic StudiesJeffery A Gladding, James P Bacci, Scott A Shaw, et al.
Journal of the American Chemical Society|January 19, 2006
Enantioselective TADMAP-catalyzed carboxyl migration reactions for the synthesis of stereogenic quaternary carbonScott A Shaw, Pedro Aleman, Justin Christy, et al.
Angewandte Chemie (International Ed. in English)|July 7, 2016
Nickel-Catalyzed Cross-Coupling of Redox-Active Esters with Boronic AcidsJie Wang, Tian Qin, Tie-Gen Chen, et al.
Angewandte Chemie (International Ed. in English)|June 22, 2017
Decarboxylative AlkynylationJoel M Smith, Tian Qin, Rohan R Merchant, et al.
Nature|April 21, 2017
Decarboxylative alkenylationJacob T Edwards, Rohan R Merchant, Kyle S McClymont, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Triazolopyridine Myeloperoxidase InhibitorsNicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Medchemcomm|August 16, 2018
Triazolopyrimidines identified as reversible myeloperoxidase inhibitorsFranck Duclos, Lynn M Abell, David G Harden, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidaseScott A Shaw, Benjamin P Vokits, Andrew K Dilger, et al.
Pageof 2